CD137L Polyclonal Antibody

    • Catalog No.:YT0723
    • Applications:WB;IF;ELISA
    • Reactivity:Human;Rat;Mouse;
      • Target:
      • CD137L
      • Fields:
      • >>Cytokine-cytokine receptor interaction
      • Gene Name:
      • TNFSF9
      • Protein Name:
      • Tumor necrosis factor ligand superfamily member 9
      • Human Gene Id:
      • 8744
      • Human Swiss Prot No:
      • P41273
      • Mouse Swiss Prot No:
      • P41274
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human TNFSF9. AA range:31-80
      • Specificity:
      • CD137L Polyclonal Antibody detects endogenous levels of CD137L protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. IF 1:200 - 1:1000. ELISA: 1:20000. Not yet tested in other applications.
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • TNFSF9;Tumor necrosis factor ligand superfamily member 9;4-1BB ligand;4-1BBL
      • Observed Band(KD):
      • 23kD
      • Background:
      • The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This transmembrane cytokine is a bidirectional signal transducer that acts as a ligand for TNFRSF9/4-1BB, which is a costimulatory receptor molecule in T lymphocytes. This cytokine and its receptor are involved in the antigen presentation process and in the generation of cytotoxic T cells. The receptor TNFRSF9/4-1BB is absent from resting T lymphocytes but rapidly expressed upon antigenic stimulation. The ligand encoded by this gene, TNFSF9/4-1BBL, has been shown to reactivate anergic T lymphocytes in addition to promoting T lymphocyte proliferation. This cytokine has also been shown to be required for the optimal CD8 responses in CD8 T cells. This cytokine is expressed in carcinoma cell lines, and is thought to be involved in T cell-tumor cell interaction.[provided b
      • Function:
      • function:Cytokine that binds to TNFRSF9. Induces the proliferation of activated peripheral blood T-cells. May have a role in activation-induced cell death (AICD). May play a role in cognate interactions between T-cells and B-cells/macrophages.,similarity:Belongs to the tumor necrosis factor family.,subunit:Homotrimer .,tissue specificity:Expressed in brain, placenta, lung, skeletal muscle and kidney.,
      • Subcellular Location:
      • Membrane; Single-pass type II membrane protein.
      • Expression:
      • Expressed in brain, placenta, lung, skeletal muscle and kidney.
      • Products Images
      • Western Blot analysis of various cells using CD137L Polyclonal Antibody diluted at 1:1000
      • Western Blot analysis of HuvEc cells using CD137L Polyclonal Antibody diluted at 1:1000
      • Immunofluorescence analysis of HeLa cells, using TNFSF9 Antibody. The picture on the right is blocked with the synthesized peptide.
      • Western blot analysis of lysates from HUVEC cells, using TNFSF9 Antibody. The lane on the right is blocked with the synthesized peptide.